203 related articles for article (PubMed ID: 30119684)
1. The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma.
Ma MW; Gao XS; Gu XB; Xie M; Cui M; Zhang M; Liu L; Yin H; Chen LQ
World J Surg Oncol; 2018 Aug; 16(1):172. PubMed ID: 30119684
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
[TBL] [Abstract][Full Text] [Related]
4. Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study.
Jo YY; Yu J; Song KJ; Jang JY; Yoo YJ; Kim SB; Park SR; Kim YH; Kim HR; Kim JH
Radiother Oncol; 2021 Sep; 162():112-118. PubMed ID: 34265356
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
[TBL] [Abstract][Full Text] [Related]
6. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
7. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
[TBL] [Abstract][Full Text] [Related]
8. Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma.
Yamaguchi T; Kato K; Nagashima K; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Ito Y; Itami J; Boku N; Higuchi K
Int J Clin Oncol; 2018 Aug; 23(4):652-658. PubMed ID: 29520523
[TBL] [Abstract][Full Text] [Related]
9. Outcomes for Esophageal Squamous Cell Carcinoma Treated with Curative Intent in a Western Cohort: Should Multimodal Therapy Be the Gold Standard?
Sheil F; Donohoe CL; King S; O'Toole D; Cunningham M; Cuffe S; Ravi N; Reynolds JV
World J Surg; 2018 May; 42(5):1485-1495. PubMed ID: 29075858
[TBL] [Abstract][Full Text] [Related]
10. Propensity score analysis of oesophageal cancer treatment with surgery or definitive chemoradiotherapy.
Karran A; Blake P; Chan D; Reid TD; Davies IL; Kelly M; Roberts SA; Crosby T; Lewis WG
Br J Surg; 2014 Apr; 101(5):502-10. PubMed ID: 24615406
[TBL] [Abstract][Full Text] [Related]
11. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion.
Yamaguchi S; Morita M; Yamamoto M; Egashira A; Kawano H; Kinjo N; Tsujita E; Minami K; Ikebe M; Ikeda Y; Kunitake N; Toh Y
Ann Surg Oncol; 2018 Oct; 25(11):3280-3287. PubMed ID: 30051363
[TBL] [Abstract][Full Text] [Related]
13. Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer.
Faiz Z; van Putten M; Verhoeven RHA; van Sandick JW; Nieuwenhuijzen GAP; van der Sangen MJC; Lemmens VEPP; Wijnhoven BPL; Plukker JTM
Ann Surg Oncol; 2019 Apr; 26(4):986-995. PubMed ID: 30719634
[TBL] [Abstract][Full Text] [Related]
14. Patient selection for salvage surgery after definitive chemoradiotherapy in esophageal squamous cell carcinoma.
Harada H; Yamashita K; Katada C; Ishiyama H; Soeno T; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Hiki N
Langenbecks Arch Surg; 2020 Sep; 405(6):767-776. PubMed ID: 32671456
[TBL] [Abstract][Full Text] [Related]
15. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
[TBL] [Abstract][Full Text] [Related]
17. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
[TBL] [Abstract][Full Text] [Related]
19. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
20. Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer.
Jiang W; Verma V; Haque W; Moreno AC; Koshy M; Butler EB; Teh BS
Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31504359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]